Georgia Hunter said...
Hard to keep up will all the questions...
Well you've been saying all along that “increased CA activity from wearing masks increases viral load” and that “it's all about
viral load” so my essential questions have been around that. When you answer with pseudomonas and TB, then I have to ask additional questions like "what does that have to do with sars-cov-2 increasing viral load?" Malaria which reproduces inside RBCs.. why bring it up when viruses cannot reproduce inside RBCs? I'm not trying to insult your intelligence or anything.. just trying to stay on track and making sure I am understanding you correctly.
The quote you provided explains how RBCs can be used in mammalian systems as a decoy, to prevent viral replication. So if this is happening in covid-19 by way of CA, then increased CA activity would be decreasing viral load.
Aside from that, we have better reason to suspect CD147 as the route of RBC damage. I brought this up earlier and you still haven’t commented: CD147 is a known route of infection for sars-cov-2. No speculating is necessary.. and CD147 is expressed by RBCs. There are other ideas out there as well about
RBC damage. I think you're clinging too tightly to sars-cov-2 binding CA without offering much in support of the idea.. only that another pathogen has been found to bind it. I don't even think you've named the other pathogen. Maybe there's something I'm missing here?
Georgia Hunter said...
As for experiments with CA Inhibitors, yes, they have been done.
In covid-19? I could not find this.
Georgia Hunter said...
I don't agree with your statement on selecting hosts it would more likely kill.
This is a misunderstanding.. check my post again including the quote of yours that I was responding to. I believe we are on the same page now: binding to CA would be a feature that harms sars-cov-2 in natural selection (“survival of the fittest”).
Georgia Hunter said...
Internal molecules often determine the exterior configuration of a membrane bound molecule. That is just common molecular biology.
Yeah I am admittedly out of my comfort zone here but I am familiar with attachment sites being altered in this way. Before I thought you were saying the virus could still attach to cells via ACE2 but not enter when CA was involved. Anyway, I’m not comfortable with an assumption that CA alters the configuration of ACE-2 so that sars-cov-2 can no longer attach.. it seems like a pretty big leap to take without evidence. Furthermore I wouldn't even have known we were taking this leap if I didn't scrutinize your statement at the top of this page:
"...there are things that can bind the inside of the ACE2 receptor and prevent entry into the cell. Carbonic anhydrase is such an item."
...I mean you said it there as if there was no question.
Also, you previously seemed to be saying that sars-cov-2 binding to CA increases viral load (but now we’ve settled on the opposite). How else can you explain this statement from the op:
"Big molecules like Ivermectin that have a lot of stereochemistry may block the viral binding to carbonic anhydrase and stop replication"
...sure sounds like you thought the virus was binding CA in order to replicate inside RBCs. I gotta wonder how much of this is being made up as we go.